Kayla L. Frost

Attenuated Ochratoxin A Transporter Expression in a Mouse Model of Nonalcoholic Steatohepatitis Protects against Proximal Convoluted Tubule Toxicity

S. Wright, N. Cherrington, J. Jilek, 2021, Drug Metabolism and Disposition.

Predicting disruptions to drug pharmacokinetics and the risk of adverse drug reactions in non-alcoholic steatohepatitis patients

N. Cherrington, S. Marie, Kayla L. Frost, 2022, Acta pharmaceutica Sinica. B.

Altered cisplatin pharmacokinetics during nonalcoholic steatohepatitis contributes to reduced nephrotoxicity

N. Cherrington, J. Jilek, M. Goedken, 2020, Acta pharmaceutica Sinica. B.

Increased Renal Expression of Complement Components in Patients with Liver Diseases: Nonalcoholic Steatohepatitis, Alcohol-Associated, Viral Hepatitis, and Alcohol-Viral Combination.

D. D. Billheimer, R. Schnellmann, N. Cherrington, 2022, Toxicological sciences : an official journal of the Society of Toxicology.

Renal Transporter Alterations in Patients with Chronic Liver Diseases: Nonalcoholic Steatohepatitis, Alcohol-Associated, Viral Hepatitis, and Alcohol-Viral Combination

S. Wright, D. Billheimer, N. Cherrington, 2022, Drug Metabolism and Disposition.

Mechanistic Basis of Increased Susceptibility to Nephrotoxicants in Chronic Liver Disease

N. Cherrington, Kayla L. Frost, Solène Marié, 2022, Current Opinion in Toxicology.

Altered cisplatin pharmacokinetics during nonalcoholic steatohepatitis contributes to reduced nephrotoxicity

N. Cherrington, Michael J Goedken, J. Jilek, 2021, Acta pharmaceutica Sinica. B.